Protection against Reinfection with the Omicron BA.2.75 Subvariant
N Engl J Med
.
2023 Feb 16;388(7):665-667.
doi: 10.1056/NEJMc2214114.
Epub 2023 Jan 18.
Authors
Hiam Chemaitelly
1
,
Patrick Tang
2
,
Peter Coyle
3
,
Hadi M Yassine
4
,
Hebah A Al-Khatib
4
,
Maria K Smatti
4
,
Mohammad R Hasan
2
,
Houssein H Ayoub
4
,
Heba N Altarawneh
5
,
Zaina Al-Kanaani
3
,
Einas Al-Kuwari
3
,
Andrew Jeremijenko
3
,
Anvar H Kaleeckal
3
,
Ali N Latif
3
,
Riyazuddin M Shaik
3
,
Hanan F Abdul-Rahim
4
,
Gheyath K Nasrallah
4
,
Mohamed G Al-Kuwari
6
,
Adeel A Butt
3
,
Hamad E Al-Romaihi
7
,
Mohamed H Al-Thani
7
,
Abdullatif Al-Khal
3
,
Roberto Bertollini
7
,
Laith J Abu-Raddad
8
;
National Study Group for COVID-19 Epidemiology
Affiliations
1
Weill Cornell Medicine-Qatar, Doha, Qatar hsc2001@qatar-med.cornell.edu.
2
Sidra Medicine, Doha, Qatar.
3
Hamad Medical Corporation, Doha, Qatar.
4
Qatar University, Doha, Qatar.
5
Weill Cornell Medicine-Qatar, Doha, Qatar.
6
Primary Health Care Corporation, Doha, Qatar.
7
Ministry of Public Health, Doha, Qatar.
8
Weill Cornell Medicine-Qatar, Doha, Qatar lja2002@qatar-med.cornell.edu.
PMID:
36652342
PMCID:
PMC9878583
DOI:
10.1056/NEJMc2214114
No abstract available
Publication types
Letter
MeSH terms
COVID-19* / prevention & control
COVID-19* / therapy
COVID-19* / virology
Humans
Reinfection* / prevention & control
Supplementary concepts
SARS-CoV-2 variants